NEW YORK (GenomeWeb) – University of Liverpool (UL) researchers said today that they have received £1.6 million ($2.2 million) to develop a commercial blood test to improve the diagnosis and management of patients with suspected meningitis, a brain infection that causes disability and sometimes death.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.